Manganese decreases glutamate uptake in cultured astrocytes

Alan S. Hazell, Michael D Norenberg

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 μM manganese for 2 days resulted in a 54% decrease in the uptake of D- aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28% decline in V(max), with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21%, and a combination of 5 mM NH4Cl with 100 μM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.

Original languageEnglish
Pages (from-to)1443-1447
Number of pages5
JournalNeurochemical Research
Volume22
Issue number12
DOIs
StatePublished - Nov 6 1997

Fingerprint

Manganese
Astrocytes
Hepatic Encephalopathy
Glutamic Acid
D-Aspartic Acid
Ammonia
Chronic Brain Damage
Basal Ganglia
Kinetics
Therapeutics

Keywords

  • Ammonia
  • Astrocyte
  • Glutamate transport
  • Hepatic encephalopathy
  • Manganese

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry

Cite this

Manganese decreases glutamate uptake in cultured astrocytes. / Hazell, Alan S.; Norenberg, Michael D.

In: Neurochemical Research, Vol. 22, No. 12, 06.11.1997, p. 1443-1447.

Research output: Contribution to journalArticle

@article{1037d5c8da964f8ba6bf7cf25fce9d6e,
title = "Manganese decreases glutamate uptake in cultured astrocytes",
abstract = "Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 μM manganese for 2 days resulted in a 54{\%} decrease in the uptake of D- aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28{\%} decline in V(max), with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21{\%}, and a combination of 5 mM NH4Cl with 100 μM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.",
keywords = "Ammonia, Astrocyte, Glutamate transport, Hepatic encephalopathy, Manganese",
author = "Hazell, {Alan S.} and Norenberg, {Michael D}",
year = "1997",
month = "11",
day = "6",
doi = "10.1023/A:1021994126329",
language = "English",
volume = "22",
pages = "1443--1447",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Manganese decreases glutamate uptake in cultured astrocytes

AU - Hazell, Alan S.

AU - Norenberg, Michael D

PY - 1997/11/6

Y1 - 1997/11/6

N2 - Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 μM manganese for 2 days resulted in a 54% decrease in the uptake of D- aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28% decline in V(max), with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21%, and a combination of 5 mM NH4Cl with 100 μM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.

AB - Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 μM manganese for 2 days resulted in a 54% decrease in the uptake of D- aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28% decline in V(max), with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21%, and a combination of 5 mM NH4Cl with 100 μM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.

KW - Ammonia

KW - Astrocyte

KW - Glutamate transport

KW - Hepatic encephalopathy

KW - Manganese

UR - http://www.scopus.com/inward/record.url?scp=0030831158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030831158&partnerID=8YFLogxK

U2 - 10.1023/A:1021994126329

DO - 10.1023/A:1021994126329

M3 - Article

VL - 22

SP - 1443

EP - 1447

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 12

ER -